Key result
In a mouse model of breast cancer, exercise training did not prevent or reverse the associated decrease in exercise capacity and subclinical left ventricular dysfunction.
Why the study?
Patients treated for breast cancer have a high incidence of cardiovascular complications, prompting evaluation of breast cancer's impact on cardiac function and cardiomyocyte Ca2+-handling protein expression, and whether exercise training prevents these alterations.
Does exercise training prevent or reverse cardiac dysfunction and Ca2+-handling protein dysregulation in a mouse model of breast cancer?
Does exercise training prevent or reverse cardiac dysfunction and Ca2+-handling protein dysregulation in a mouse model of breast cancer?
In a mouse model of breast cancer, tumor development is associated with subclinical left ventricular dysfunction and altered calcium handling that is not reversed by exercise training.
Breast cancer impairs LV function via Ca²⁺-handling dysregulation in mice, unaffected by ET; leaves open whether similar mechanisms apply in patients.
Background Patients treated for breast cancer have a high incidence of cardiovascular complications. In this study, we evaluated the impact of breast cancer on cardiac function and cardiomyocyte Ca 2+ ‐handling protein expression. We also investigated whether exercise training (ET) would prevent these potential alterations. Methods and Results Transgenic mice with spontaneous breast cancer (mouse mammary tumor virus–polyomavirus middle T antigen [MMTV‐PyMT+], n=15) and littermate mice with no cancer (MMTV‐PyMT−, n=14) were studied. For the ET analysis, MMTV‐PyMT+ were divided into sedentary (n=10) and exercise‐trained (n=12) groups. Cardiac function was evaluated by echocardiography with speckle‐tracking imaging. Exercise tolerance test was conducted on a treadmill. Both studies were performed when the tumor became palpable and when it reached 1 cm 3 . After euthanasia, Ca 2+ ‐handling protein expression (Western blot) was evaluated. Exercise capacity was reduced in MMTV‐PyMT+ compared with MMTV‐PyMT− ( P interaction =0.031). Longitudinal strain ( P group <0.001) and strain rate ( P group =0.030) were impaired. Cardiomyocyte phospholamban was increased ( P =0.011), whereas phospho‐phospholamban and sodium/calcium exchanger were decreased ( P =0.038 and P =0.017, respectively) in MMTV‐PyMT+. No significant difference in sarcoplasmic or endoplasmic reticulum calcium 2 ATPase (SERCA2a) was found. SERCA2a/phospholamban ratio was reduced ( P =0.007). ET was not associated with increased exercise capacity. ET decreased left ventricular end‐systolic diameter ( P group =0.038) and end‐diastolic volume ( P group =0.026). Other morphological and functional cardiac parameters were not improved by ET in MMTV‐PyMT+. ET did not improve cardiomyocyte Ca 2+ ‐handling protein expression. Conclusions Breast cancer is associated with decreased exercise capacity and subclinical left ventricular dysfunction in MMTV‐PyMT+, which is at least partly associated with dysregulation of cardiomyocyte Ca 2+ handling. ET did not prevent or reverse these changes.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2021) studied Breast cancer-induced cardiac dysfunction (n=29). Exercise training vs. Sedentary was evaluated on Exercise capacity, cardiac function, and cardiomyocyte Ca2+-handling protein expression. In a mouse model of breast cancer, exercise training did not prevent or reverse the associated decrease in exercise capacity and subclinical left ventricular dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: